BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11171904)

  • 1. The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese.
    Wu RM; Cheng CW; Chen KH; Lu SL; Shan DE; Ho YF; Chern HD
    Neurology; 2001 Feb; 56(3):375-82. PubMed ID: 11171904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population.
    Torkaman-Boutorabi A; Ali Shahidi G; Choopani S; Reza Zarrindast M
    Folia Neuropathol; 2012; 50(4):382-9. PubMed ID: 23319194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.
    Białecka M; Droździk M; Kłodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Stankiewicz J
    Acta Neurol Scand; 2004 Oct; 110(4):260-6. PubMed ID: 15355491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD.
    Hernán MA; Checkoway H; O'Brien R; Costa-Mallen P; De Vivo I; Colditz GA; Hunter DJ; Kelsey KT; Ascherio A
    Neurology; 2002 May; 58(9):1381-7. PubMed ID: 12011284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.
    Białecka M; Droździk M; Honczarenko K; Gawrońska-Szklarz B; Stankiewicz J; Dabrowska E; Kubisiak M; Kłodowska-Duda G; Opala G
    Eur Neurol; 2005; 53(2):68-73. PubMed ID: 15753616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD.
    Zhang Y; Piao X; Wu J; Li Y; Liang Q
    Int J Neurosci; 2016; 126(5):400-7. PubMed ID: 26000819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The catechol-O-methyltransferase and monoamine oxidase B polymorphisms and levodopa therapy in the Iranian patients with sporadic Parkinson's disease.
    Torkaman-Boutorabi A; Shahidi GA; Choopani S; Rezvani M; Pourkosary K; Golkar M; Zarrindast MR
    Acta Neurobiol Exp (Wars); 2012; 72(3):272-82. PubMed ID: 23093014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.
    Kumudini N; Umai A; Devi YP; Naushad SM; Mridula R; Borgohain R; Kutala VK
    Indian J Biochem Biophys; 2013 Oct; 50(5):436-41. PubMed ID: 24772965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease.
    Bialecka M; Klodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Safranow K; Droździk M
    Parkinsonism Relat Disord; 2007 May; 13(4):224-9. PubMed ID: 17270484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional monoamine oxidase B gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson's disease.
    Löhle M; Mangone G; Wolz M; Beuthien-Baumann B; Oehme L; van den Hoff J; Kotzerke J; Reichmann H; Corvol JC; Storch A
    Mov Disord; 2018 Sep; 33(9):1496-1501. PubMed ID: 30216543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes.
    McGregor NW; Hemmings SMJ; Erdman L; Calmarza-Font I; Stein DJ; Lochner C
    Psychiatry Res; 2016 Dec; 246():527-532. PubMed ID: 27821364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease.
    Sampaio TF; Dos Santos EUD; de Lima GDC; Dos Anjos RSG; da Silva RC; Asano AGC; Asano NMJ; Crovella S; de Souza PRE
    J Clin Pharmacol; 2018 Jul; 58(7):920-926. PubMed ID: 29578580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.
    Hao H; Shao M; An J; Chen C; Feng X; Xie S; Gu Z; Chan P;
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1041-5. PubMed ID: 25034874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior.
    Tochigi M; Suzuki K; Kato C; Otowa T; Hibino H; Umekage T; Kato N; Sasaki T
    Pharmacogenet Genomics; 2007 Oct; 17(10):867-72. PubMed ID: 17885625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.
    Mellick GD; Buchanan DD; McCann SJ; James KM; Johnson AG; Davis DR; Liyou N; Chan D; Le Couteur DG
    Mov Disord; 1999 Mar; 14(2):219-24. PubMed ID: 10091612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.
    Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
    BMC Neurol; 2011 Jul; 11():89. PubMed ID: 21781348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability and validity of polymorphism association studies in Parkinson's disease.
    Tan EK; Khajavi M; Thornby JI; Nagamitsu S; Jankovic J; Ashizawa T
    Neurology; 2000 Aug; 55(4):533-8. PubMed ID: 10953187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
    Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
    Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
    Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
    J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships of Cerebrospinal Fluid Alzheimer's Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms.
    Babić Leko M; Nikolac Perković M; Klepac N; Švob Štrac D; Borovečki F; Pivac N; Hof PR; Šimić G
    J Alzheimers Dis; 2020; 73(1):135-145. PubMed ID: 31771069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.